319 related articles for article (PubMed ID: 25775435)
1. D-cycloserine enhances generalization of fear extinction in children.
Byrne SP; Rapee RM; Richardson R; Malhi GS; Jones M; Hudson JL
Depress Anxiety; 2015 Jun; 32(6):408-14. PubMed ID: 25775435
[TBL] [Abstract][Full Text] [Related]
2. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.
Guastella AJ; Dadds MR; Lovibond PF; Mitchell P; Richardson R
J Psychiatr Res; 2007 Sep; 41(6):466-71. PubMed ID: 16828803
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
Norberg MM; Krystal JH; Tolin DF
Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
[TBL] [Abstract][Full Text] [Related]
5. D-cycloserine-augmented one-session treatment of specific phobias in children and adolescents.
Farrell LJ; Waters AM; Oar EL; Tiralongo E; Garbharran V; Alston-Knox C; McConnell H; Collings N; Zimmer-Gembeck M; Donovan CL; Testa C; Storch EA; Ollendick TH
Brain Behav; 2018 Jun; 8(6):e00984. PubMed ID: 30106248
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
[TBL] [Abstract][Full Text] [Related]
7. Generalization of Extinguished Fear to Untreated Fear Stimuli after Exposure.
Preusser F; Margraf J; Zlomuzica A
Neuropsychopharmacology; 2017 Dec; 42(13):2545-2552. PubMed ID: 28589965
[TBL] [Abstract][Full Text] [Related]
8. Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder.
de Kleine RA; Smits JA; Hendriks GJ; Becker ES; van Minnen A
J Anxiety Disord; 2015 Aug; 34():63-7. PubMed ID: 26121495
[TBL] [Abstract][Full Text] [Related]
9. D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia.
Smits JA; Rosenfield D; Otto MW; Powers MB; Hofmann SG; Telch MJ; Pollack MH; Tart CD
Biol Psychiatry; 2013 Jun; 73(11):1054-8. PubMed ID: 23332511
[TBL] [Abstract][Full Text] [Related]
10. Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: a randomized pilot study.
Nave AM; Tolin DF; Stevens MC
J Clin Psychiatry; 2012 Sep; 73(9):1179-86. PubMed ID: 23059145
[TBL] [Abstract][Full Text] [Related]
11. D-cycloserine as adjunct to brief computerised CBT for spider fear: Effects on fear, behaviour, and cognitive biases.
Kappelmann N; Suesse M; Steudte-Schmiedgen S; Kaldewaij R; Browning M; Michael T; Rinck M; Reinecke A
J Behav Ther Exp Psychiatry; 2020 Sep; 68():101546. PubMed ID: 31951819
[TBL] [Abstract][Full Text] [Related]
12. D-cycloserine does not facilitate fear extinction by reducing conditioned stimulus processing or promoting conditioned inhibition to contextual cues.
Baker KD; McNally GP; Richardson R
Learn Mem; 2012 Sep; 19(10):461-9. PubMed ID: 22984284
[TBL] [Abstract][Full Text] [Related]
13. Fear extinction learning as a predictor of response to cognitive behavioral therapy for pediatric obsessive compulsive disorder.
Geller DA; McGuire JF; Orr SP; Small BJ; Murphy TK; Trainor K; Porth R; Wilhelm S; Storch EA
J Anxiety Disord; 2019 May; 64():1-8. PubMed ID: 30852257
[TBL] [Abstract][Full Text] [Related]
14. Cognitive-behavioural therapy with post-session D-cycloserine augmentation for paediatric obsessive-compulsive disorder: pilot randomised controlled trial.
Mataix-Cols D; Turner C; Monzani B; Isomura K; Murphy C; Krebs G; Heyman I
Br J Psychiatry; 2014 Jan; 204(1):77-8. PubMed ID: 24262813
[TBL] [Abstract][Full Text] [Related]
15. Effects of D-cycloserine on extinction: translation from preclinical to clinical work.
Davis M; Ressler K; Rothbaum BO; Richardson R
Biol Psychiatry; 2006 Aug; 60(4):369-75. PubMed ID: 16919524
[TBL] [Abstract][Full Text] [Related]
16. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
Hofmann SG; Carpenter JK; Otto MW; Rosenfield D; Smits JA; Pollack MH
Contemp Clin Trials; 2015 Jul; 43():223-30. PubMed ID: 26111923
[TBL] [Abstract][Full Text] [Related]
17. Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response.
Acheson DT; Feifel D; Kamenski M; Mckinney R; Risbrough VB
Depress Anxiety; 2015 Jun; 32(6):400-7. PubMed ID: 25826649
[TBL] [Abstract][Full Text] [Related]
18. Post-exposure cortisol administration does not augment the success of exposure therapy: A randomized placebo-controlled study.
Raeder F; Merz CJ; Tegenthoff M; Wolf OT; Margraf J; Zlomuzica A
Psychoneuroendocrinology; 2019 Jan; 99():174-182. PubMed ID: 30245330
[TBL] [Abstract][Full Text] [Related]
19. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.
Difede J; Cukor J; Wyka K; Olden M; Hoffman H; Lee FS; Altemus M
Neuropsychopharmacology; 2014 Apr; 39(5):1052-8. PubMed ID: 24217129
[TBL] [Abstract][Full Text] [Related]
20. Augmenting extinction learning with D-cycloserine reduces return of fear: a randomized, placebo-controlled fMRI study.
Ebrahimi C; Gechter J; Lueken U; Schlagenhauf F; Wittchen HU; Hamm AO; Ströhle A
Neuropsychopharmacology; 2020 Feb; 45(3):499-506. PubMed ID: 31634897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
